20045 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
Tannin-chitosan composites
#602MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A STEROID
#603Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
#604SUSPENSION AEROSOL FORMULATIONS OF PHARMACEUTICAL PRODUCTS
#605Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#606CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
#607MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC
#608Respiratory dispersion for metered dose inhalers comprising perforated microstructures
#609Co-polymer stabilizers for hydrofluoroalkane dispersions
#610Aerosols for sinunasal drug delivery
#611Pharmaceutical compositions based on anticholingerics and additional active ingredients
#612CONCENTRATED AQUEOUS AZALIDE FORMULATIONS
#613Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease
#614Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
#615COMPOSITIONS FOR TREATING PARKINSON'S DISEASE
#616Composition for inhalation
#617Pulmonary delivery particles comprising an active agent
#618LEVALBUTEROL SALT
#619INHALATION PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO] ETHYL]-2(1H)-QUINOLINONE AND A CORTICOSTEROID
#620Organic Compounds
#621ORGANIC COMPOUNDS
#622Prenylated Bisphosphonates as Anti-tuberculosis Agents
#623Device for intranasal administration
#624Compositions and methods of making brittle-matrix particles through blister pack freezing
#625Method of making particles for use in a pharmaceutical composition
#626Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#627INHALATION DELIVERY METHODS AND DEVICES
#628Inhalation devices and related methods for administration of sedative hypnotic compounds
#629AEROSOL FORMULATION
#630PHARMACEUTICAL FORMULATIONS
#631PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA
#632Formulations for Delivery Via Pressurised Metered Dose Inhalers Comprising an Essential Oil as Suspension Stabiliser
#633Aerosol dispersions of particles with active pharmaceutical ingredients
#634PHARMACEUTICAL COMPOSITIONS
#635Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
#636Treprostinil administration by inhalation
#637NON-AQUEOUS LIQUID FORMULATION FOR NASAL OR BUCCAL ADMINISTRATION
#638COMBINATIONS OF FORMOTEROL AND FLUTICASONE PROPIONATE FOR ASTHMA
#639Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide Antibiotics
#640USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#641Method of prophylaxis of infection
#642COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LEUKOTRIENE RECEPTOR ANTAGONIST FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#643Pharmaceutical aerosol composition
#644Selective Targeting of Apoptotic Cells
#645R-RAS activity in vascular regulation
#646Magnet-field controlled active substance transfer for aerosol therapy
#647Preparation of suspension aerosol formulations
#648Particulate materials
#649Glycopeptide antibiotic derivative
#650Compositions containing fluorine substituted olefins
#651COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#652PRESSURISED METERED DOSE INHALERS CONTAINING SOLUTIONS OF BETA-2 AGONISTS
#653COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTI-IGE ANTIBODY FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#654Soft anticholinergic esters
#655Pharmaceutical compounds and compositions
#656ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#657COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT
#658Soft anticholinergic zwitterions
#659Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
#660Capped mesoporous silicates
#661MEDICINAL AEROSOL FORMULATIONS
#662Medicinal aerosols and methods of delivery thereof
#663PHARMACEUTICAL FORMULATIONS
#664Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension
#665Templated open flocs of anisotropic particles for enhanced pulmonary delivery
#666AEROSOLIZED NITRITE AND NITRIC OXIDE -DONATING COMPOUNDS AND USES THEREOF
#667MEDICAL PRODUCT
#668AEROSOL AND USE THEREOF
#669Stable aerosol pharmaceutical formulations
#670INHALABLE TIOTROPIUM AND CONTAINER THEREFOR
#671Medicaments
#672Propellant-based nanoparticulate dry powder aerosols and method of making
#673PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG
#674TIOTROPIUM CONTAINING HFC SOLUTION FORMULATIONS
#675PULMONARY DELIVERY IN TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
#676MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC
#677Solid peptide preparations for inhalation and their preparation
#678Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions
#679PHARMACEUTICAL SOLUTION FORMULATIONS FOR PRESSURISED METERED DOSE INHALERS
#680Novel Formulations
#681Compositions comprising an active agent
#682SUSPENSION AEROSOL FORMULATIONS OF PHARMACEUTICAL PRODUCTS
#683Stable liquid desoximethasone compositions with reduced oxidized impurity
#684PHARMACEUTICAL COMPOSITIONS CONTAINING WATER-SOLUBLE DERIVATIVES OF PROPOFOL AND METHODS OF ADMINISTERING SAME VIA PULMONARY ADMINISTRATION
#685Concentrated aqueous azalide formulations
#686Soft anticholinergic esters
#687Acetamide stereoisomer
#688Phospholipid-based powders for drug delivery
#689MEDICAL PRODUCT
#690Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough, asthma and tussive attacks
#691Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#692TREATMENT METHODS
#693Compositions and methods for the treatment of respiratory disorders
#694INHALABLE TIOTROPIUM AND CONTAINER THEREFOR
#695Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
#696Nanoparticulate formulations and methods for the making and use therof
#697DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
#698DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
#699Organic Compounds Comprising a Glycopyrrolium Salt
#700Aerosol Canister Employing a Polymeric Film Having Improved Moisture Barrier Properties
#701Combination Of Dehydroepiandrosterone Or Dehydroepiandrosterone-Sulfate With An Anticholinergic Bronchodilator For Treatment Of Asthma Or Chronic Obstructive Pulmonary Disease
#702Propellant for Dosing Aerosols Comprising Packagings
#703Organic Compounds Comprising a Glycopyrr Onium Salt
#704Medicinal compositions and method for the preparation thereof
#705Process for milling poorly soluble drugs in presence of liquid propellants
#706Stable Pharmaceutical Drug Products
#707PRESSURISED METERED DOSE INHALERS (MDI)
#708Soft anticholinergic zwitterions
#709Dispersion for pulmonary delivery of a bioactive agent
#710Respiratory dispersion for metered dose inhalers
#711Pharmaceutical Formulations
#712TREPROSTINIL ADMINISTRATION USING A METERED DOSE INHALER
#713Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
#714Pharmaceutical Composition
#715DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
#716DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
#717Phospholipid-based inhalation system
#718Levalbuterol salt
#719Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation
#720Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining
#721Biocompatible Polymer Compounds For Medicinal Formulations
#722Stable pharmaceutical budesonide preparation for producing propellant-free aerosols
#723Compositions and methods for the prevention and control of insulin-induced hypoglycemia
#724METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
#725Pulmonary delivery of active fragments parathyroid hormone
#726Pharmaceutical Compositions
#727Pharmaceutical Compositions for Inhalation Containing an Anticholinergic, Corticosteroid, and Betamimetic
#728Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
#729HFA suspension formulations containing an anticholinergic
#730AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS
#731Aerosol canister employing a polymeric film having improved moisture barrier properties
#732Soft anticholinergic zwitterions
#733Pharmaceutical compositions
#734Lung Surfactant Supplements
#735Metered dose inhaler
#736METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
#737Methods for pulmonary delivery of interleukin-2
#738Amorphous, spray-dried powders having a reduced moisture content and a high long term stability
#739Compositions containing fluorine substituted olefins and methods and systems using same
#740Intranasal administration of ketamine to treat depression
#741Enhanced delivery of drug compositions to treat life threatening infections
#742Medicinal Aerosol Formulations and Methods of Synthesizing Ingredients Therefor
#743STABLE AEROSOL PHARMACEUTICAL FORMULATIONS
#744Quinolinone-carboxamide compounds as 5-HTreceptor agonists
#745Polysulfated glycosides and salts thereof
#746Combination of anticholineric and β mimetics for the treatment of respiratory diseases
#747Aerosol Formulations Comprising Formoterol Fumarate Dihydrate
#748Method of Administration of Dopamine Receptor Agonists
#749Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
#750HFA supension formulations containing an anticholinergic
#751Stable S-nitrosothiol formulations
#752Medication spray formulation
#753Intranasal or inhalational administration of virosomes
#754Aerosol Formulation Comprising Formoterol in Suspension
#755Dispersion for pulmonary delivery of a bioactive agent
#756Pharmaceutical Formulations
#757Pharmaceutical Formulations
#758cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction
#759Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#760Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
#761Particles
#762Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#763Composition for inhalation therapy and methods of use
#764Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same
#765Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant
#766Adrenergic complement inhaler
#767Methods for smoking cessation or alcohol cessation or other addiction cessation
#768Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
#769Pharmaceutical Compositions Based on Tiotropium Salts and Salts of Salmeterol
#770Aerosolized capreomycin for inhibition of pulmonary tuberculosis
#771TIOTROPIUM CONTAINING HFC SOLUTION FORMULATIONS
#772Soft anticholinergic esters
#773Inhalation Drug Combinations
#774Inhalation Drug Combinations
#775Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases
#776Pharmaceutical metered dose inhaler and methods relating thereto
#777Inhalable tiotropium and container therefor
#778Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin
#779Dronabinol treatment for migraines
#780Combination of medicaments for the treatment of respiratory diseases
#781Medicinal Aerosol Formulation Products With Improved Chemical Stability
#782Dry powder composition comprising a benzodiazepine for pulmonary inhalation
#783Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles
#784Method for the Protection Against the Risk of Cardiac Disorders Comprising Administration of Tiotropium Salts
#785Advantageous combination for inhalation of nacystelyn and bronchodilators
#786Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
#787Suspension aerosol formulationis of pharmaceutical products
#788Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
#789HFC SOLUTION FORMULATIONS CONTAINING SALBUTAMOL HYDROCHLORIDE OR SALBUTAMOL CITRATE
#790Diphenylmethyl compounds useful as muscarinic receptor antagonists
#791Use of ciclesonide for the treatment of respiratory diseases
#792Stable Pharmaceutical Solution Formulations for Pressurized Metered Dose Inhalers
#793Dronabinol compositions and methods for using same
#794Aerosol compositions and methods
#795Stabilized dispersions comprising excipient surface-modified organic nanoparticles and medicament particles
#796Medicament compositions comprising a heterocyclic compound and an anticholinergic
#797Medicaments comprising steroids and a novel anticholinergic
#798Medicament formulations
#799Method of controlling alcohol intake and reversing alcohol effects
#800Inhalable formulations of amphotericin B and methods and devices for delivery thereof
#801Dry powder composition comprising co-jet milled particles for pulmonary inhalation
#802Medical product
#803Pharmaceutical solution formulations for pressurised metered dose inhalers
#804Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases
#805Use of osmolytes obtained from extremophilic bacteria the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component
#806Drug for airway administration
#807Reactor coated with a polymer
#808Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof
#809High viscosity liquid controlled delivery system and medical or surgical device
#810Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
#811Process for the production of a purified hydrofluoroalkane, purified hydrofluoroalkane, use of the hydrofluoroalkane and method for the analysis of a hydrofluoroalkane
#812Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
#813Water-stabilized aerosol formulation system and method of making
#814Pulmonary delivery particles comprising water insoluble or crystalline active agents
#815Solubilisation of drugs in hfa propellant by means of emulsions
#816Compositions and methods for the prevention and control of insulin-induced hypoglycemia
#817Pulmonary delivery particles with phospholipid structural matrix
#818Capped mesoporous silicates
#819Treating autoimmune diseases with humanized anti-CD401 antibodies
#820Process to minimize loss through adhesion to equipment surfaces
#821Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
#822Methods and compositions for delivery of catecholic butanes for treatment of obesity
#823Stable aerosol formulations of peptides and protein with non-cfc propellants
#824Aerosol pharmaceutical compositions
#825Stable pharmaceutical Budesonide preparation for producing propellant-free aerosols
#826Aerosol preparation comprising sealed container and enclosed therein aerosol composition containing marcolide compound
#827Diphenylmethyl compounds useful as muscarinic receptor antagonists
#828Salmeterol superfine formulation
#829Metered dose inhaler product
#830Particulate composition
#831Stable pharmaceutical solution formulations for pressurised metered dose inhalers
#832Combination of formoterol and a tiotropium salt
#833Sustanined-release pharmaceutical composition for lung administration
#834Controlled Dosage Aerosols With Lecithin As Surface-Active Agent
#835Medicaments for inhalation comprising steroids and an anticholinergic
#836Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
#837Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients
#838Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
#839Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
#840Methotrexate compositions
#841Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
#842Antimicrobial mesoporous silica nanoparticles
#843Aerosolizable formulation comprising nicotine
#844Nebulized pharmaceutical compositions for the treatment of bronchial disorders
#845Combination of formoterol and mometasone furoate for asthma
#846Synthesis and powder preparation of fluticasone propionate
#847Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant
#848Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
#849Use of mometasone furoate for treating airway passage and lung disease
#850Combinations of formoterol and fluticasone propionate for asthma
#851Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon
#852Compounds for use as surfactants
#853Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
#854Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
#855Formoterol and mometasone aerosol formulations
#856Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
#857Composition for inhalation therapy and methods for use
#858Mucin synthesis inhibitors
#859Aerosol composition
#860Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
#861Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
#862Formulations limiting spread of pulmonary infections
#863Stable pharmaceutical solution formulations for pressurized metered dose inhalers
#864Steroid solution aerosol products with enhanced chemical stability
#865Dry powder preparations
#866Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
#867Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
#868Aerosol formulations containing P134a and particulate medicament
#869Stabilized preparations for use in nebulizers
#870Formoterol and ciclesonide aerosol formulations
#871Diphenylmethyl compounds useful as muscarinic receptor antagonists
#872Treatment methods
#873Valve for aerosol container
#874Inhalable aerosol medicament for the treatment or prevention of pain
#875Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases
#876Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
#877Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
#878Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
#879Carboxylic acid compounds for use as surfactants
#880Pressurised metered dose inhalers containing solutions of beta-2 agonists
#881Pharmaceutical compositions based on a scopineester and nicotinamide derivatives
#882Formoterol superfine formulation
#883Pharmaceutical compositions based on anticholinergics and additional active ingredients
#884Compositions comprising an active agent
#885Pharmaceutical compositions for the treatment of asthma
#886Pressurised metered dose inhalers (MDI)
#887Method for the production and the use of microparticles and nanoparticles by constructive micronisation
#888Pharmaceutical compositions
#889Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
#890Formulations for inhalation
#891Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections
#892Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
#893Medical product
#894Inhalable tiotropium and container therefor
#895Composition for inhalation
#896Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
#897Treatment of cancers by inhalation of stable platinum-containing formulations
#898Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
#899Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#900Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease